National Bank of Canada’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11 | Sell |
6
-21
| -78% | -$38 | ﹤0.01% | 2575 |
|
|
2025
Q1 | $54 | Sell |
27
-37
| -58% | -$74 | ﹤0.01% | 2421 |
|
|
2024
Q4 | $381 | Sell |
64
-84
| -57% | -$500 | ﹤0.01% | 2351 |
|
|
2024
Q3 | $1.45K | Sell |
148
-15
| -9% | -$147 | ﹤0.01% | 2204 |
|
|
2024
Q2 | $3.06K | Buy |
163
+24
| +17% | +$450 | ﹤0.01% | 2205 |
|
|
2024
Q1 | $4.63K | Buy |
139
+22
| +19% | +$732 | ﹤0.01% | 2127 |
|
|
2023
Q4 | $5.49K | Buy |
117
+44
| +60% | +$2.06K | ﹤0.01% | 2108 |
|
|
2023
Q3 | $2.81K | Buy |
73
+38
| +109% | +$1.46K | ﹤0.01% | 2238 |
|
|
2023
Q2 | $3.77K | Hold |
35
| – | – | ﹤0.01% | 2221 |
|
|
2023
Q1 | $10.6K | Sell |
35
-8
| -19% | -$2.42K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $14.6K | Hold |
43
| – | – | ﹤0.01% | 1919 |
|
|
2022
Q3 | $8K | Sell |
43
-3
| -7% | -$558 | ﹤0.01% | 2059 |
|
|
2022
Q2 | $10K | Hold |
46
| – | – | ﹤0.01% | 2052 |
|
|
2022
Q1 | $15K | Sell |
46
-3
| -6% | -$978 | ﹤0.01% | 2020 |
|
|
2021
Q4 | $16K | Buy |
+49
| New | +$16K | ﹤0.01% | 1991 |
|